Neumirna Therapeutics specializes in the development of miRNA-based therapies within the biotechnology sector, focusing on neurological diseases
Neumirna Therapeutics specializes in the development of miRNA-based therapies within the biotechnology sector, focusing on neurological diseases. The company offers treatments for conditions such as epilepsy and Parkinson's disease, emphasizing an approach that seeks to address their underlying mechanisms.